A founder asks for licorice, rosemary or a probiotic. A supplier sends a brochure. The INCI appears correct, so the material is added to the brief. But the INCI name is only the beginning of the sourcing decision.
The actual raw material may differ in extraction, carrier, concentration, active marker, strain, preservation, colour, odour, processing tolerance and evidence. Those details determine how it behaves in the beaker; and whether the story you want is attached to the material you are buying.
Botanical extracts are not interchangeable
Take a plant extract. Questions include species and plant part, geographic source where relevant, extraction solvent, drug-to-extract ratio, standardised compounds, residual solvents, colour and odour range, pesticide or heavy-metal documentation, adulteration controls and the carrier used in the supplied liquid or powder.
A study on a defined root extract cannot automatically be mapped to any product bearing the plant name. Even two materials with the same apparent INCI may have different active-marker levels and formula effects.
Strains, ferments and postbiotics need precision
“Probiotic skincare” is often used loosely. A material may contain live organisms, a ferment filtrate, lysate or isolated metabolites. Strain identity, viability, processing and preservation are not small distinctions; they change the whole formula and the language that may be appropriate.
For body care, material grade, use level and exposure pattern can be just as central to evidence relevance. A rinse-off treatment and a leave-on formula cannot borrow the same broad ingredient halo without examining contact time, format and finished-product testing.
Grades change the development problem
Particle size, molecular weight, purity, salt form, coating or encapsulation can alter solubility, skin feel, colour, stability and delivery. Hyaluronic acid is not one sensorial object. Neither is niacinamide, a peptide solution or a mineral powder.
A useful ingredient Blueprint names the technical property that matters. If a polymer is intended to create short-term mask grip but disappear after drydown, its rheology and film behaviour matter more than the generic category. If a powder must remain elegant on deeper skin tones, particle and dispersion choices enter the brief.
The label name tells you what to declare. The specification tells you what you are formulating with.
Audit the full composition
Many raw materials are blends. The active may arrive in water, glycerin, glycol or oil, with stabilisers, antioxidants or preservatives. These subcomponents affect total formula composition, label order, allergen review, retailer criteria, preservation load and sometimes sensory performance.
Request the full composition or breakdown permitted by the supplier, along with technical and safety data. If an important detail is proprietary, ask the supplier or laboratory to confirm the relevant compliance question in writing.
The supplier file to assemble
- Trade name, supplier and manufacturing site or region where relevant
- INCI and complete composition or subcomponent statement
- Technical data, specification and current certificate of analysis
- Safety data and recommended use range
- Solubility, pH, heat and shear constraints
- Microbiological limits, preservatives and allergens where applicable
- Evidence package tied to the exact branded material
- Regulatory, retailer or certification statements needed for selected markets
- MOQ, lead time, price basis and a qualified alternative
Connect specification to claims
If the brand story relies on an active marker, record it. If the supplier study uses a particular percentage of a branded ingredient, compare that with the formula’s realistic level and route. If the evidence is mainly mechanistic or preclinical, do not quietly turn it into a finished-product clinical claim.
Marketing can still tell a compelling ingredient story. Precision makes it more compelling because the brand can explain why this version of the material was selected.
Specify alternatives by function
A resilient brief includes alternatives without treating ingredients as identical. Define what the substitute must preserve: active marker, solubility, sensory profile, cultural provenance, documentation, cost range or claim relevance. When a lead time changes, the team can make a controlled decision rather than restart the concept.
That is the difference between naming ingredients and architecting them. The first fills a list. The second gives the laboratory, regulatory reviewer, supplier and marketing team the same product to talk about.
The Formula Blueprint connects your INCI, specifications, manufacturing logic, suppliers, claims and lab iterations in one working document.
Start your edit